Biomaterial-associated infection: A perspective from the clinic

Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies

Volumn 9781461410317, Issue , 2013, Pages 3-24

  Zimmerli, Werner ^a   Trampuz, Andrej ^b  

^a Kantonsspital Liestal   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL AGENTS; DIAGNOSIS; MICROORGANISMS;

ANTIBIOTIC THERAPY; BACTERIAL INFECTIONS; DEBRIDEMENT; FOREIGN BODIES; FUNGAL INFECTION; HOST DEFENSE; IMPLANT-ASSOCIATED INFECTION; INOCULA; MEDICAL DEVICES; PROSTHETIC JOINTS;

BIOFILMS;

EID: 84884817002     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1031-7_1     Document Type: Chapter

References (120)

1. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237:1588-95.
2. Costerton JW, Montanaro L, Arciola CR. Bio film in implant infections: its production and regulation. Int J Artif Organs. 2005;28:1062-8.
3. Wolcott R, Dowd S. The role of bio films: are we hitting the right target? Plast Reconstr Surg. 2011;127 Suppl 1:28S-35S.
4. Hall-Stoodley L, Stoodley P. Evolving concepts in bio film infections. Cell Microbiol. 2009;11:1034-43.
5. Parsek MR, Singh PK. Bacterial bio films: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677-701.
6. Zimmerli W. Tissue cage infection model. In: Zak O, Sande M, editors. Handbook of animal models of infection. London: Academic Press Ltd.; 1999. p. 409-17.
7. Furustrand U, Majic I, Belkhodja Zalila C, et al. Gentamicin improves the activity of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2011;55:4821-7.
8. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-9.
9. Zimmerli W, Trampuz A. Implant-associated infection. In: Bjarnsholt T, Hoiby N, Moser C, Jensen PO, editors. Bio film infections. 1st ed. Heidelberg: Springer; 2011. p. 69-90.
10. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
11. De Man FH, Sendi P, Zimmerli W, et al. Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm. Acta Orthop. 2011;82:27-34.
12. Zimmerli W. Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol. 2006;20:1045-63.
13. Anderson JM, McNally AK. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin Immunopathol. 2011;33:221-33.
14. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20:86-100.
15. Peck MK, Dusserre N, Zagalski K, et al. New biological solutions for hemodialysis access. J Vasc Access. 2011;12(3):185-92.
16. Hannah EL, Stevenson KB, Lowder CA, et al. Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol. 2002;23:538-41.
17. Chiesa R, Marone EM, Tshomba Y, et al. Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease. Ann Vasc Surg. 2009;23:764-9.
18. Viola GM, Darouiche RO. Cardiovascular implantable device infections. Curr Infect Dis Rep. 2011;13:333-42.
19. Raber L, Wohlwend L, Wigger M, et al. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation. 2011;123:2819-28.
20. Grunwald IQ, Kuhn AL. Controversies around carotid stenting. Acta Chir Belg. 2011;111:63-7.
21. Antonios VS, Baddour LM. Intra-arterial device infections. Curr Infect Dis Rep. 2004;6:263-9.
22. Malone JM, Moore WS, Campagna G, et al. Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function. Surgery. 1975;78:211-6.
23. Moore WS, Malone JM, Keown K. Prosthetic arterial graft material. Influence on neointimal healing and bacteremic infectibility. Arch Surg. 1980;115:1379-83.
24. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
25. Hammermeister KE, Sethi GK, Henderson WG, et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med. 1993;328:1289-96.
26. Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152-8.
27. Oxenham H, Bloom field P, Wheatley DJ, et al. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003;89:715-21.
28. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scienti fic statement from the American Heart Association. Circulation. 2010;121:458-77.
29. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med. 2009;361:787-94.
30. Ong KL, Kurtz SM, Lau E, et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24:105-9.
31. Lethaby A, Temple J, Santy J. Pin site care for preventing infections associated with external bone fixators and pins. Cochrane Database Syst Rev. 2008:CD004551.
32. Mueller ME, Allgoewer M, Willenegger H. Mass survey by a study group on osteosynthesis problems. Langenbecks Arch Klin Chir Ver Dtsch Z Chir. 1963;304:808-17.
33. Clauss M, Trampuz A, Borens O, et al. Bio film formation on bone grafts and bone graft substitutes: comparison of different materials by a standard in vitro test and microcalorimetry. Acta Biomater. 2011;6:3791-7.
34. Evans RP. Current concepts for clean air and total joint arthroplasty: laminar airflow and ultraviolet radiation: a systematic review. Clin Orthop Relat Res. 2011;469:945-53.
35. Krenek L, Farng E, Zingmond D, et al. Complication and revision rates following total elbow arthroplasty. J Hand Surg Am. 2011;36:68-73.
36. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep. 2008;10:394-403.
37. Sendi P, Frei R, Maurer TB, et al. Escherichia coli variants in periprosthetic joint infection: diagnostic challenges with sessile bacteria and sonication. J Clin Microbiol. 2011;48:1720-5.
38. Vaudaux P, Fran?ois P, Waldvogel F. Host factors predisposing to and influencing therapy of foreign body infections. In: Waldvogel FA, editor. Infections associated with undwelling medical devices. 3rd ed. Washington: ASM Press; 2000. p. 173-205 39. Zimmerli W, Waldvogel FA, Vaudaux P, et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis. 1982;146:487-97.
39. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest. 1984;73:1191-200.
40. Kristian SA, Birkenstock TA, Sauder U, et al. Bio film formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis. 2008;197:1028-35.
41. Verhoef J. The phagocytic process and the role of complement in host defense. J Chemother. 1991;3 Suppl 1:93-7.
42. Zimmerli W, Zarth A, Gratwohl A, et al. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood. 1991;77:393-9.
43. Kristian SA, Golda T, Ferracin F, et al. The ability of bio film formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb Pathog. 2004;36:237-45.
44. Zimmerli W, Sendi P. Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol. 2011;33:295-306.
45. Bernard L, Vaudaux P, Merle C, et al. The inhibition of neutrophil antibacterial activity by ultra-high molecular weight polyethylene particles. Biomaterials. 2005;26:5552-7.
46. Hosman AH, van der Mei HC, Bulstra SK, et al. Effects of metal-on-metal wear on the host immune system and infection in hip arthroplasty. Acta Orthop. 2010;81:526-34.
47. Bohler J, Kramer P, Gotze O, et al. Leucocyte counts and complement activation during pumpdriven and arteriovenous haemo filtration. Contrib Nephrol. 1983;36:15-25.
48. Hammerschmidt DE, Craddock PR, McCullough F, et al. Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis. Blood. 1978;51:721-30.
49. Shepard AD, Gelfand JA, Callow AD, et al. Complement activation by synthetic vascular prostheses. J Vasc Surg. 1984;1:829-38.
50. Anderson JM. Inflammatory response to implants. ASAIO Trans. 1988;34:101-7.
51. Tang L, Liu L, Elwing HB. Complement activation and inflammation triggered by model biomaterial surfaces. J Biomed Mater Res. 1998;41:333-40.
52. Noordin S, Shortkroff S, Sledge CB, et al. Investigation of the activation of a human serum complement protein, C3, by orthopedic prosthetic particulates. Biomaterials. 2004;25:5347-52.
53. Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol. 1957;38:573-86.
54. Widmer AF, Frei R, Rajacic Z, et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990;162:96-102.
55. Vaudaux PE, Zulian G, Huggler E, et al. Attachment of Staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immun. 1985;50:472-7.
56. Borlee BR, Goldman AD, Murakami K, et al. Pseudomonas aeruginosa uses a cyclic-di-GMPregulated adhesin to reinforce the bio film extracellular matrix. Mol Microbiol. 2010;75: 827-42.
57. Lindsay D, von Holy A. Bacterial bio films within the clinical setting: what healthcare professionals should know. J Hosp Infect. 2006;64:313-25.
58. Widmer AF, Colombo VE, Gachter A, et al. Salmonella infection in total hip replacement: tests to predict the outcome of antimicrobial therapy. Scand J Infect Dis. 1990;22:611-8.
59. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-5.
60. Fevang BT, Lie SA, Havelin LI, et al. Risk factors for revision after shoulder arthroplasty: 1,825 shoulder arthroplasties from the Norwegian Arthroplasty Register. Acta Orthop. 2009;80:83-91.
61. Kim BS, Knupp M, Zwicky L, et al. Total ankle replacement in association with hindfoot fusion: outcome and complications. J Bone Joint Surg Br. 2010;92:1540-7.
62. Achermann Y, Vogt M, Spormann C, et al. Characteristics and outcome of 27 elbow periprosthetic joint infections: results from a 14-year cohort study of 358 elbow prostheses. Clin Microbiol Infect. 2011;17:432-8.
63. Lüem M. Patient population. In: Ochsner PE, editor. Total hip replacement: implantation technique and local complications. Berlin: Springer; 2003. p. 5-13.
64. Steckelberg JM, Osmon DR. Prosthetic joint infection. In: Waldvogel FA, ed. Infections associated with indwelling medical devices. 3rd ed. Washington, DC: ASM Press; 2000. p. 173-205.
65. Trampuz A, Hanssen AD, Osmon DR, et al. Synovialfluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med. 2004;117:556-62.
66. Schinsky MF, Della Valle CJ, Sporer SM, et al. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am. 2008;90:1869-75.
67. Osmon D, Berbari E, Berendt A, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2012 (in press)
68. Parvizi J, Jacovides C, Zmistowski B, et al. De finition of periprosthetic joint infection: is there a consensus? Clin Orthop Relat Res. 2011;469(11):3022-30.
69. Maderazo EG, Judson S, Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res. 1988;229:131-42.
70. Murdoch DR, Roberts SA, Fowler Jr VG, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis. 2001;32:647-49.
71. Lalani T, Chu VH, Grussemeyer CA, et al. Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand J Infect Dis. 2008;40:973-7.
72. Sendi P, Banderet F, Graber P, et al. Periprosthetic joint infection following Staphylococcus aureus bacteremia. J Infect. 2011;63:17-22.
73. Zimmerli W, Zak O, Vosbeck K. Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis. 1985;17:303-10.
74. Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010;50:8-16.
75. Zimmerli W, Sendi P. Antibiotics for prevention of periprosthetic joint infection following dentistry: time to focus on data. Clin Infect Dis. 2010;50:17-9.
76. Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg. 2000;120:570-4.
77. Segawa H, Tsukayama DT, Kyle RF, et al. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am. 1999;81:1434-45.
78. Marculescu CE, Cantey JR. Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res. 2008;466:1397-404.
79. Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J Bone Joint Surg Am. 1990;72:878-83.
80. Salvati EA, Robinson RP, Zeno SM, et al. Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg Am. 1982;64:525-35.
81. Fitzgerald Jr RH, Nolan DR, Ilstrup DM, et al. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. 1977;59:847-55.
82. Rand JA, Fitzgerald Jr RH. Diagnosis and management of the infected total knee arthroplasty. Orthop Clin North Am. 1989;20:201-10.
83. Wymenga AB, van Horn JR, Theeuwes A, et al. Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. Acta Orthop Scand. 1992;63:665-71.
84. Berbari EF, Hanssen AD, Duffy MC, et al. Risk factors for prosthetic joint infection: casecontrol study. Clin Infect Dis. 1998;27:1247-54.
85. Kessler B, Sendi P, Graber P et al. Risk factors for periprosthetic ankle joint infection: a hospital-based case-control study. J Bone Joint Surg Am. 2012 (in revision).
86. Berbari E, Mabry T, Tsaras G, et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am. 2010;92:2102-9.
87. Piper KE, Fernandez-Sampedro M, Steckelberg KE, et al. C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One. 2010;5:e9358.
88. Tigges S, Stiles RG, Roberson JR. Appearance of septic hip prostheses on plain radiographs. AJR. 1994;163:377-80.
89. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, et al. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med. 2010;40:3-15.
90. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908-13.
91. Graute V, Feist M, Lehner S, et al. Detection of low-grade prosthetic joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results. Eur J Nucl Med Mol Imaging. 2010;37:1751-9.
92. Strobel K, Stumpe KD. PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol. 2007;11:353-64.
93. Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging. 2008;35:2122-32.
94. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39:66-78.
95. Bori G, Soriano A, Garcia S, et al. Low sensitivity of histology to predict the presence of microorganisms in suspected aseptic loosening of a joint prosthesis. Mod Pathol. 2006;19:874-7.
96. Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol. 1998;36:2932-9.
97. Zappe B, Graf S, Ochsner PE, et al. Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge. Arch Orthop Trauma Surg. 2008;128:1039-46.
98. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med. 2007;357:654-63.
99. Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly. 2005;135:243-51.
100. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537-41.
101. Byren I, Bejon P, Atkins BL, et al. One hundred and twelve infected arthroplasties treated with ?DAIR? (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63:1264-71.
102. Giulieri SG, Graber P, Ochsner PE, et al. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection. 2004;32:222-8.
103. Laffer RR, Graber P, Ochsner PE, et al. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect. 2006;12:433-9.
104. Sendi P, Christensson B, Uckay I, et al. Group B streptococcus in prosthetic hip and knee joint-associated infections. J Hosp Infect. 2011;79:64-9.
105. Sendi P, Rohrbach M, Graber P, et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis. 2006;43:961-7.
106. Stengel D, Bauwens K, Sehouli J, et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis. 2001;1:175-88.
107. Zimmerli W, Frei R, Widmer AF, et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus . J Antimicrob Chemother. 1994;33:959-67.
108. Widmer AF, Wiestner A, Frei R, et al. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother. 1991;35:741-6.
109. Schwank S, Rajacic Z, Zimmerli W, et al. Impact of bacterial bio film formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother. 1998;42:895-8.
110. Baldoni D, Haschke M, Rajacic Z, et al. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother. 2009;53:1142-8.
111. John AK, Baldoni D, Haschke M, et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus : importance of combination with rifampin. Antimicrob Agents Chemother. 2009;53:2719-24.
112. Trampuz A, Murphy CK, Rothstein DM, et al. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother. 2007;51:2540-5.
113. Osmon DR, Berbari EF. Outpatient intravenous antimicrobial therapy for the practicing orthopaedic surgeon. Clin Orthop Relat Res. 2002;403:80-6.
114. Batoni G, Maisetta G, Brancatisano FL, et al. Use of antimicrobial peptides against microbial bio films: advantages and limits. Curr Med Chem. 2010;18:256-79.
115. Gao G, Lange D, Hilpert K, et al. The biocompatibility and bio film resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials. 2011;32:3899-909.
116. Ketonis C, Barr S, Adams CS, et al. Bacterial colonization of bone allografts: establishment and effects of antibiotics. Clin Orthop Relat Res. 2010;468:2113-21.
117. Masse A, Bruno A, Bosetti M, et al. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;53:600-4.
118. Khare MD, Bukhari SS, Swann A, et al. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. J Infect. 2007; 54:146-50.
119. Wang CH, Lee GB. Automatic bio-sampling chips integrated with micro-pumps and microvalves for disease detection. Biosens Bioelectron. 2005;21:419-25.
120. Coelho LR, Souza RR, Ferreira FA, et al. agr RNAIII divergently regulates glucose-induced bio film formation in clinical isolates of Staphylococcus aureus . Microbiology. 2008; 154:3480-90.